Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers

Summary

About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of this study is to evaluate whether a PEer-Led O2 Infoline for patients and CAregivers (PELICAN) will increase adherence to supplemental oxygen prescription and improve health in patients with chronic obstructive pulmonary disease (COPD).

Conditions

• Chronic Obstructive Pulmonary Disease (COPD)

Interventions

BEHAVIORAL

Written education material (basic)

Education material on COPD distributed to all participants.

BEHAVIORAL

Additional education material

Additional education material sent to participants in the proactive and reactive arms.

BEHAVIORAL

PELICAN-Proactive

In the proactive arm, calls will be initiated by the coach. The phone calls will involve educational and social support components. PELICAN is grounded on the social cognitive theory of behavior change and seeks to improve patient adherence by addressing patient self-efficacy and outcome expectancy.

BEHAVIORAL

PELICAN-Reactive

Participants allocated to the reactive PELICAN group will be offered the opportunity to access the COPD Foundation Infoline toll-free.

Sponsors & Collaborators

• AlphaNet

  collaborator UNKNOWN

• Apria Healthcare

  collaborator UNKNOWN

• COPD Foundation

  collaborator OTHER

• Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

  collaborator OTHER

• National Jewish Health

  collaborator OTHER

• Patient-Centered Outcomes Research Institute

  collaborator OTHER

• American Association for Respiratory Care

  collaborator OTHER

• University of Illinois at Chicago

  lead OTHER

Principal Investigators

• Jerry A Krishnan, MD, PhD · University of Illinois at Chicago

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2015-04-30

Primary Completion

2016-09-30

Completion

2016-10-31

Countries

• United States

Study Locations